Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Medical - Instruments & Supplies

Healthcare
$28.29 -0.37%

-$0.07 today

Market cap
$1.69B
Beta
0.83
P/E (TTM)
-6.9
EPS (TTM)
-$2.74
52W Low $13.25High $30.00

Volume 0.44M

Average 0.33M

KMTS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Kestra Medical Technologies, Ltd.NASDAQ: KMTS

Cost of Revenue · Q3 FY2026 · quarter ended Jan 2026

Cost of revenue growth accelerates

Q3 FY2026 cost of revenue of $11.65M rose 36.3% year over year, ahead of the +23.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 4.5% from the prior quarter.

Context

  • Cost of revenue amounted to 59.5% of revenue in FY2025, down 39.2 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +36.3% holds above the trailing-twelve-month pace of +23.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
$11.65M+4.5% QoQ
Last fiscal yearApr 2025
$35.61M+29.7% YoY
LTMJan 2026
$42.91M+23.8% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.3%——
1 year+29.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
35.61M USD
Year-over-year change
+29.7%

Cost of Revenue vs competitors

How KMTS compares with its peers on the latest reported figures

  • KMTS's LTM Jan 2026 cost of revenue of $42.91M is the 2nd highest of the 3 companies compared; the peer median is $122.74M.
  • Its year-over-year change of +23.8% is the highest of 3, against a peer median of +6.4%.
  • Cost of revenue amounts to 51.2% of revenue for KMTS, versus a peer median of 21.1%.
KMTS Competitors Peer median
Cost of Revenue for KMTS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IRTCiRhythm Technologies, Inc.LTM Sep 2026$236.94M +13.7%+19.4%27.7%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$42.91M +23.8%—51.2%
CVRXCVRx, Inc.LTM Mar 2026$8.55M -0.9%+18.5%14.5%
Peer median (excluding KMTS) $122.74M+6.4%+18.9%21.1%

Competitors are the stored peer set for KMTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2020
Apr 2020
FY2021
Apr 2021
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue007.63M27.81M59.82M
Cost of Revenue0018.28M27.45M35.61M
Gross Profit00(10.65M)362K24.21M
Gross Margin——-139.6%1.3%40.5%
Research & Development22.8M18.81M15.76M15.49M15.65M
Selling, General & Admin6.52M13.9M54.01M69.94M114.94M
Operating Expenses29.32M32.71M69.77M85.43M130.59M
Depreciation & Amortization478K420K4.86M11.56M7.97M
EBITDA(28.84M)(32.33M)(73.74M)(76.31M)(97.98M)
EBITDA Margin——-966.4%-274.3%-163.8%
Operating Income(29.32M)(32.71M)(80.42M)(85.06M)(106.38M)
Operating Margin——-1054.0%-305.8%-177.8%
Interest Income00003.2M
Interest Expense01.17M5.63M6.23M7.73M
Other Income / Expenses0(1.21M)(3.8M)(9.03M)(7.3M)
Income Before Tax(29.32M)(33.91M)(84.22M)(94.1M)(113.68M)
Pre-Tax Margin——-1103.8%-338.3%-190.1%
Income Tax Expense148K187K15K24K135K
Net Income(29.47M)(34.1M)(84.24M)(94.12M)(113.81M)
Net Margin——-1104.0%-338.4%-190.3%
EPS (Basic)(0.59)(0.69)(1.75)(2.04)(5.13)
EPS (Diluted)(0.59)(0.69)(1.75)(2.04)(5.13)
Weighted Avg Shares49.53M49.53M49.53M49.53M49.53M
Weighted Avg Shares (Diluted)49.53M49.53M49.53M49.53M49.53M

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Intrinsic Alpha fair value

Locked

Current Price

$28.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.